Lack of clinical evidence for involvement of hepatitis C virus interferon-α sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses

Journal of Medical Virology

Volumn 61, Issue 1, 2000, Pages 29-36

  Mihm, Sabine ^a   Monazahian, Masyar ^a   Grethe, Stefanie ^a   Meier, Volker ^a   Thomssen, Reiner ^a   Ramadori, Giuliano ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Double stranded RNA dependent protein kinase; Hepatitis C virus; Interferon sensitivity determining region; Interferon ; Nonstructural protein 5A

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; PROTEIN KINASE;

ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; EIF-2 KINASE; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GTP-BINDING PROTEINS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, PROTEIN; VARIATION (GENETICS);

HEPATITIS C VIRUS; RNA VIRUSES; STAPHYLOCOCCUS PHAGE 3A;

EID: 0034080813     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(200005)61:1<29::AID-JMV5>3.0.CO;2-C     Document Type: Article

References (32)

1. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H. 1997. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
2. Clemens MJ, Elia A. 1997. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res 17:503-524.
3. Der SD, Lau AS. 1995. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc Natl Acad Sci USA 92:8841-8845.
4. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and -resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
5. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81.
6. Fitzgerald-Bocarsly P. 1993. Human natural interferon-α producing cells. Pharmacol Ther 60:39-62.
7. Fukuma T, Enomoto N, Marumo F, Sato C. 1998. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Hepatology 28:1147-1153.
8. Gale M Jr., Katze MG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther 78:29-46.
9. Gale MJ Jr., Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
10. rIPK. Mol Cell Biol 18:859-871.
11. Gale M Jr., Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998b. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208-5218.
12. Herion D, Hoofnagle JH. 1997. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 25:769-771.
13. Hofgärtner WT, Polyak SJ, Sullivan DG, Carithers RL Jr., Gretch DR. 1997. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 53:118-126.
14. Jakschies D, Zachoval R, Muller R, Manns M, Nolte KU, Hochkeppel HK, Horisberger MA, Deicher H, Von Wussow P. 1994. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C. Hepatology 19:857-865.
15. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron JP, Lunel F, Stuyver L, Duverlie G. 1997. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 27:72-77.
16. Kirchhoff S, Koromilas AE, Schaper F, Grashoff M, Sonenberg N, Hauser H. 1995. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR. Oncogene 11:439-445.
17. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. 1997. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepatology 25:750-753.
18. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62:379-390.
19. Mihm S, Hartmann H, Fayyazi A, Ramadori G. 1996a. Preferential virological response to interferon-α2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low γ-GT/ALT ratio. Dig Dis Sci 41:1256-1264.
20. Mihm S, Hutschenreiter A, Fayyazi A, Pingel S, Ramadori G. 1996b. High inflammatory activity is associated with an increased amount of IFN-γ transcripts in peripheral blood cells of patients with chronic hepatitis C virus infection. Med Microbiol Immunol (Berl) 185:95-102.
21. Mihm S, Fayyazi A, Hartmann H, Ramadori G. 1997. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25:735-739.
22. Odeberg J, Yun Z, Sonnerborg A, Weiland O, Lundeberg J. 1998. Variation in the hepatitis C virus NS5a region in relation to hypervariable region 1 heterogeneity during interferon treatment. J Med Virol 56:33-38.
23. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, et al. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
24. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. 1993. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74:2385-2390.
25. Roers A, Hochkeppel HK, Horisberger MA, Hovanessian A, Haller O. 1994. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis 169:807-813.
26. Sáiz JC, López-Labrador FX, Ampurdanés S, Dopazo J, Forns X, Sánchez-Tapias JM, Rodes J. 1998. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 177:839-847.
27. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Brechet C. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa. Gastroenterology 113:567-572.
28. Thomis DC, Doohan JP, Samuel CE. 1992 Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. Virology 188:33-46.
29. Tiwari RK, Kusari J, Kumar R, Sen GC. 1988. Gene induction by interferons and double-stranded RNA: selective inhibition by 2-aminopurine. Mol Cell Biol 8:4289-4294.
30. Wathelet MG, Clauss IM, Paillard FC, Huez GA. 1989. 2-Aminopurine selectively blocks the transcriptional activation of cellular genes by virus, double-stranded RNA and interferons in human cells. Eur J Biochem 184:503-509.
31. Zeuzem S, Lee JH, Roth WK. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25:740-744.
32. Zinn K, Keller A, Whittemore LA, Maniatis T. 1988. 2-Aminopurine selectively inhibits the induction of beta-interferon, c-fos, and c-myc gene expression. Science 240:210-213.